Explore practical solutions that bridge the gap between theory and real-world application. Stay informed about innovative developments shaping clinical cancer care.
Refer to Your Unique Access URL Mentioned in the e-Flyer to Access 2024 ASCO Annual Meeting Sessions
Lorlatinib vs crizotinib in treatment-naïve patients with advanced ALK+ non-small cell lung cancer: 5-year progression-free survival and safety from the CROWN study
Benjamin J. Solomon, PhD, MBBS
Department of Medical Oncology,
Peter MacCallum Cancer Centre
Deep-learning model for real time prediction of recurrence in early-stage non-small cell lung cancer: A multi-modal approach
Hyun Ae Jung, MD
Samsung Medical Center, PhD, MBBS